What is Sanofi - ADR Annual Revenue?

Sanofi - ADR Annual Revenue rose 6.41%, in the last year to $44,286 M. Its sector's average revenue growth for the last fiscal year was 7.47%.

What is Sanofi - ADR Annual Net Profit?

Sanofi - ADR Annual Net Profit rose 2.96% in the last year to $5,560 M. Its sector's average net profit growth for the last fiscal year was -32.45%.

What is Sanofi - ADR Price to Earning Ratio?

Sanofi - ADR Price to Earning Ratio is 24.19, higher than its sector PE ratio of 4.28.

What is Sanofi - ADR Stock Price?

Sanofi - ADR Stock Price rose 22.52% and outperformed its sector by 12.85% in the past year.

What is Sanofi - ADR Quarterly Revenue?

Sanofi - ADR Quarterly Revenue rose 3.47% YoY to $7,631 M. Its sector's average revenue growth YoY for the quarter was 5.97%.

What is Sanofi - ADR Quarterly Net profit?

Sanofi - ADR Quarterly Net profit rose 189.91% YoY to $499 M. Its sector's average net profit growth YoY for the quarter was -47.5%.

What is Sanofi - ADR Debt to Equity Ratio?

Sanofi - ADR Debt to Equity Ratio of 0.23 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Sanofi - ADR Return on Equity(ROE)?

Sanofi - ADR Return on Equity(ROE) for the last financial year was 7.34%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Sanofi - ADR Mutual Fund Holding?

Sanofi - ADR Mutual Fund Holding decreased by 0.1% in the last quarter to 5.73.

What is Sanofi - ADR Interest Coverage Ratio?

Sanofi - ADR Interest Coverage Ratio is 9.94, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Sanofi - ADR Institutional Holding?

Sanofi - ADR Institutional Holding decreased by 0.76% in the last quarter to 10.62.

How is the Sanofi - ADR today?

The Sanofi - ADR today is trading in the down by -0.86% at 58.60.

How has Sanofi - ADR performed historically?

The Sanofi - ADR is currently trading down -0.86% on an intraday basis in the past week the index fell -0.24%. The index has been up 24.65% in the past quarter and rose 22.52% in the past year. You can view this in the overview section.

Sanofi - ADR XNAS: SNY

Sanofi - ADR Live Share Price Today, Share Analysis and Chart

Name: Sanofi - ADR: Is Infosys Ltd. worth buying?
Item: Sanofi - ADR
Rating: 2.327277625
Author: Trendlyne DVM scores

Mid-range Performer

Download real time

58.60 -0.51 (-0.86%)

Near 52W High of $60.12

3.2M XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Sanofi - ADR Key Metrics

My Metrics

Select

Market Capitalization High in industry Unavailable in chosen country	146,920.9
PE TTM High in industry Unavailable in chosen country	24.2
PEG TTM High in industry Unavailable in chosen country	8.2
Price to Book Below industry Median Unavailable in chosen country	1.7
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	10.6
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	3.5
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	6.4
Net Profit Qtr Growth YoY % High in industry Unavailable in chosen country	189.9
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	3
Operating Profit Margin Qtr % Below industry Median Unavailable in chosen country	11.3
Operating Profit Margin TTM % High in industry Unavailable in chosen country	21.4
Piotroski Score High in industry Unavailable in chosen country	6
Rel Perf vs Sector quarter% Unavailable in chosen country	17.4
ROE Annual % High in industry Unavailable in chosen country	7.3
RoA Annual % High in industry Unavailable in chosen country	4.3

All financials are in EUR Million and price data in USD

Medium Financial Strength

44.4 / 100

Mid Valuation

41.8 / 100

Technically Neutral

55.5 / 100

Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM

1Yr Price target upside is 10%

7 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Neutral Zone

54.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Sanofi - ADR Stock Price Analysis

Day Price Range -0.9% 1 Day return Unavailable in chosen country	58.6 (LTP) 58.259.1 LowHigh
Week Price Range -0.2% 1 Week return Unavailable in chosen country	58.6 (LTP) 57.359.2 LowHigh
Month Price Range 8.6% 1 Month return Unavailable in chosen country	58.6 (LTP) 53.560.1 LowHigh
52 Week Price Range 22.5% 1 Year return Unavailable in chosen country	58.6 (LTP) 45.260.1 LowHigh

View full Share Price History

Sanofi - ADR Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Miss

Sanofi - ADR's Revenue was lower than average estimate 3 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

2.4

Avg. Estimate

5.9

Low Estimate

3.3

High Estimate

8.4

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 145.2% in FY25

Consensus Recommendation

8 ANALYST Recommendations

BUY

The consensus recommendation from 8 analysts for Sanofi - ADR is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Sanofi - ADR Stock Analysis

Sanofi - ADR stock analysis with key metrics, changes, and trends.

Sanofi - ADR Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$44,286 M	6.41%	positive	Annual Revenue rose 6.41%, in the last year to $44,286 M. Its sector's average revenue growth for the last fiscal year was 7.47%.
Annual Net Profit	$5,560 M	2.96%	positive	Annual Net Profit rose 2.96% in the last year to $5,560 M. Its sector's average net profit growth for the last fiscal year was -32.45%.
Price to Earning Ratio	24.19	-	negative	Price to Earning Ratio is 24.19, higher than its sector PE ratio of 4.28.
Stock Price	$58.60	22.52%	positive	Stock Price rose 22.52% and outperformed its sector by 12.85% in the past year.
Quarterly Revenue	$7,631 M	3.47%	positive	Quarterly Revenue rose 3.47% YoY to $7,631 M. Its sector's average revenue growth YoY for the quarter was 5.97%.
Quarterly Net profit	$499 M	189.91%	positive	Quarterly Net profit rose 189.91% YoY to $499 M. Its sector's average net profit growth YoY for the quarter was -47.5%.
Debt to Equity Ratio	0.23	-	positive	Debt to Equity Ratio of 0.23 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	7.34 %	7.34%	negative	Return on Equity(ROE) for the last financial year was 7.34%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	5.73 %	-0.1%	negative	Mutual Fund Holding decreased by 0.1% in the last quarter to 5.73.
Interest Coverage Ratio	9.94	-	positive	Interest Coverage Ratio is 9.94, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
Institutional Holding	10.62 %	-0.76%	negative	Institutional Holding decreased by 0.76% in the last quarter to 10.62.

VIEW LESS

Loading data..

Sanofi - ADR - Company Profile

What does Sanofi - ADR do?

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

167.5 K

2024

Gross Remuneration

Year

Sanofi - ADR Live Share Price Today, Share Analysis and Chart

Near 52W High of $60.12

Sanofi - ADR Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

Check Before You Buy

Check P/E Buy Sell Zone

Sanofi - ADR Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Sanofi - ADR Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Sanofi - ADR's Revenue was lower than average estimate 3 times in past 3 years

EPS forecast

EPS is expected to grow by 145.2% in FY25

Consensus Recommendation

The consensus recommendation from 8 analysts for Sanofi - ADR is BUY

Sanofi - ADR Stock Analysis

Sanofi - ADR stock analysis with key metrics, changes, and trends.

Annual Revenue rose 6.41%, in the last year to $44,286 M. Its sector's average revenue growth for the last fiscal year was 7.47%.

Annual Net Profit rose 2.96% in the last year to $5,560 M. Its sector's average net profit growth for the last fiscal year was -32.45%.

Price to Earning Ratio is 24.19, higher than its sector PE ratio of 4.28.

Stock Price rose 22.52% and outperformed its sector by 12.85% in the past year.

Quarterly Revenue rose 3.47% YoY to $7,631 M. Its sector's average revenue growth YoY for the quarter was 5.97%.

Quarterly Net profit rose 189.91% YoY to $499 M. Its sector's average net profit growth YoY for the quarter was -47.5%.

Debt to Equity Ratio of 0.23 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was 7.34%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 0.1% in the last quarter to 5.73.

Interest Coverage Ratio is 9.94, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding decreased by 0.76% in the last quarter to 10.62.

Sanofi - ADR - Company Profile

What does Sanofi - ADR do?

Sanofi - ADR Management structure

Mr. Francois-Xavier Roger

Executive Vice President and Chief Financial Officer

Mr. Olivier Charmeil

Executive Vice President, General Medicines

Mr. Paul Hudson

Director and Chief Executive Officer

Mr. Jean-Baptiste Chasseloup De Chatillon

Executive Vice President and Chief Financial Officer

Ms. Natalie Bickford

Executive Vice President and Chief People Officer

Ms. Julie Van Ongevalle

Executive Vice President, Consumer Healthcare

Sanofi - ADR Board of directors

Ms. Carole Ferrand

Independent Director

Mr. Patrick Kron